Kemadrin and Pregnancy
No adequate studies have been done on Kemadrin (procyclidine hydrochloride) and pregnancy, so it is not known if it is safe to use this medication during pregnancy. Kemadrin is considered a pregnancy Category C medication, as it has not been studied in any pregnant women or animals. If you are taking Kemadrin and pregnancy occurs, talk to your healthcare provider.
Kemadrin® (procyclidine hydrochloride) is a prescription medication approved to treat Parkinson's disease and certain side effects of antipsychotic medications. Almost no information is available about the use of Kemadrin in pregnant women.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans, but do appear to cause harm to the fetus in animal studies. Also, medicines that have not been adequately studied in any pregnant women or animals are automatically given a "default" pregnancy Category C rating.
Although Kemadrin does not have an official pregnancy Category rating (as is common with older medications like Kemadrin), most sources consider it to be a Category C medication, as it has not been adequately studied in any pregnant women or animals.
If you are pregnant or thinking about becoming pregnant, let your healthcare provider know. He or she will consider the benefits and risks of taking Kemadrin during pregnancy before making a recommendation in your particular situation.